Skip to main content

Table 2 Summary of AEs reported in more than one subject (safety population)

From: The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma

 

MEM 1414

Placebo

N = 16 (%)

N = 16 (%)

Subjects who reported any AEs

13 (81.3)

9 (56.3)

 

Nausea

7 (43.8)

2 (12.5)

 

Headache

6 (37.5)

2 (12.5)

 

Diarrhoea

4 (25.0)

0

 

Vomiting

3 (18.8)

0

 

Dizziness

3 (18.8)

1 (6.3)

 

Chest discomfort

2 (12.5)

2 (12.5)

 

Dysgeusia

1 (6.3)

2 (12.5)